Zuhua Chen

Systematic profiling of alternative splicing signature reveals prognostic predictor for ovarian cancer

Junyong Zhu, Zuhua Chen, Yong Lei · Gynecologic Oncology · 2017 · 113 citations

Life Sciences, Molecular Biology, Oncology +14

Dual PI3K/mTOR inhibitor BEZ235 as a promising therapeutic strategy against paclitaxel-resistant gastric cancer via targeting PI3K/Akt/mTOR pathway

Dongshao Chen, Xiaoting Lin, Cheng Zhang et al. · Cell Death and Disease · 2018 · 101 citations · Full text

Medicine, Oncology, Pharmacology +17

CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest

Jiayuan Wang, Qingqing Li, Jiajia Yuan et al. · Journal of Translational Medicine · 2017 · 87 citations · Full text

Medicine, Oncology, Pharmacology +17

Targeting c-Myc: JQ1 as a promising option for c-Myc-amplified esophageal squamous cell carcinoma

Jingyuan Wang, Zhentao Liu, Ziqi Wang et al. · Cancer Letters · 2018 · 54 citations

Medicine, Molecular Genetics, Oncology +12

A novel oral camptothecin analog, gimatecan, exhibits superior antitumor efficacy than irinotecan toward esophageal squamous cell carcinoma in vitro and in vivo

Jianling Zou, Shuang Li, Zuhua Chen et al. · Cell Death and Disease · 2018 · 53 citations · Full text

Medicine, Oncology, Pharmacology +16